Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arepanrix H1N1 Vaccine in Aboriginal Children and Adults
NCT01001026Phase 4Completed
- Start
- Nov 2009
- Primary completion
- Feb 2010
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in H1N1 influenza (H1N1). Started Nov 2009; status: completed.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
H1N1 influenza (H1N1)
Beyond the preview
Go deeper on NCT01001026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001026.